Abstract
Bacillus Calmette-Guérin (BCG) is a vaccine that is used worldwide to prevent tuberculosis. Some developed countries, such as the United States, do not routinely administer this vaccine. This article presents the case study of a family who struggled to obtain the BCG in the months before a planned trip to a country in which tuberculosis is prevalent. The application of the BCG vaccination and its availability in the United States, particularly for children, is discussed.
DOI
10.46743/1540-580X/2009.1224
Recommended Citation
Raja D. Case Study of the Access to the Bacillus Calmette-Guérin Vaccine Against Tuberculosis in the United States. The Internet Journal of Allied Health Sciences and Practice. 2009 Jan 01;7(1), Article 5.
